Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
712完成签到,获得积分10
1秒前
YY关注了科研通微信公众号
2秒前
嘿小黑发布了新的文献求助10
2秒前
2秒前
li完成签到,获得积分10
2秒前
Yuki发布了新的文献求助20
3秒前
3秒前
强砸发布了新的文献求助10
3秒前
田様应助henwunai7106采纳,获得10
3秒前
4秒前
留胡子的裘完成签到 ,获得积分10
4秒前
楚眠发布了新的文献求助10
5秒前
5秒前
干净的琦应助许小六采纳,获得10
7秒前
7秒前
7秒前
7秒前
8秒前
明亮听芹发布了新的文献求助10
8秒前
研友_VZG7GZ应助合适一斩采纳,获得10
9秒前
9秒前
CAt5完成签到,获得积分10
9秒前
10秒前
搞怪的熠彤完成签到,获得积分10
10秒前
漂亮思菱发布了新的文献求助10
10秒前
鲸落发布了新的文献求助10
11秒前
CC发布了新的文献求助10
11秒前
12秒前
彳亍1117应助留胡子的书双采纳,获得10
12秒前
12秒前
wjf发布了新的文献求助10
13秒前
wanci应助景泉采纳,获得10
14秒前
杨怡红发布了新的文献求助10
14秒前
14秒前
CodeCraft应助kangkang采纳,获得10
14秒前
14秒前
14秒前
15秒前
munire发布了新的文献求助10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6032705
求助须知:如何正确求助?哪些是违规求助? 7722753
关于积分的说明 16201263
捐赠科研通 5179362
什么是DOI,文献DOI怎么找? 2771782
邀请新用户注册赠送积分活动 1755051
关于科研通互助平台的介绍 1640057